-
preventiveservices.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/prp/prp-wound-care.pdf
September 17, 2020 - and general health (e.g.,
status of HbA1c, diabetes, peripheral vascular disease, obesity,
smoking, renal … Gender
Comorbidities (e.g., status of HbA1c,
diabetes, peripheral vascular disease,
obesity, smoking, renal … A list of the studies excluded at the full-text review stage is in Appendix C.
Key Question 1. … Several studies mentioned that if wound closure was complete prior to the
end of the planned treatment … One study plans to apply dressing with PRP every 3
days until 90% wound healing, with no specific end
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/prp/prp-wound-care.pdf
September 17, 2020 - and general health (e.g.,
status of HbA1c, diabetes, peripheral vascular disease, obesity,
smoking, renal … Gender
Comorbidities (e.g., status of HbA1c,
diabetes, peripheral vascular disease,
obesity, smoking, renal … A list of the studies excluded at the full-text review stage is in Appendix C.
Key Question 1. … Several studies mentioned that if wound closure was complete prior to the
end of the planned treatment … One study plans to apply dressing with PRP every 3
days until 90% wound healing, with no specific end
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/prp/prp-wound-care.pdf
September 17, 2020 - and general health (e.g.,
status of HbA1c, diabetes, peripheral vascular disease, obesity,
smoking, renal … Gender
Comorbidities (e.g., status of HbA1c,
diabetes, peripheral vascular disease,
obesity, smoking, renal … A list of the studies excluded at the full-text review stage is in Appendix C.
Key Question 1. … Several studies mentioned that if wound closure was complete prior to the
end of the planned treatment … One study plans to apply dressing with PRP every 3
days until 90% wound healing, with no specific end
-
hcup-us.ahrq.gov/reports/methods/2019-01.pdf
January 01, 2019 - The AHRQ QI measures generated for possible inclusion in the QDR are described in Table 1
at the end … the AHRQ PQI software, diabetes must be the
principal diagnosis and long-term complications include renal … Exclusions include the
following: admissions with a diagnosis code for chronic renal
failure and transfers … software, the following cases are excluded: admissions with
a principal diagnosis of pressure ulcer stage … with the AHRQ PSI software, the following cases are excluded:
obstetric cases; admissions with acute renal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/autoimmune-disease-rapid-research.pdf
November 01, 2024 - The program has begun to develop a range of rapid evidence products to assist end
users in making specific … At this stage, we excluded articles that did not describe dental
treatments, used healthy controls as … Year
Title DOI Exclusion Reason
Trivedi
2018
Novel PAradigm to improve Inflammatory burden in end … stage Renal disease (rePAIR): study protocol for a
randomized controlled trial
10.1186/s13063-
018
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/oPmYxryXGu2occANaReagc
August 01, 2022 - Related article at
jamanetworkopen.com
Author Affiliations: Author
affiliations are listed at the end … Diagram: Screening for Latent Tuberculosis Infection in Adults
3275 Excluded at title and abstract stage … 413 Excluded at title and abstract stage
188 Wrong population
48 Wrong intervention
45 Wrong study … (53 included studies) used a mixed-
treatment comparison methodology and focused on 2 prespecified
end … household or close contacts of persons with
active tuberculosis without confirmed LTBI; and persons with renal
-
www.ahrq.gov/sites/default/files/wysiwyg/teamstepps/diagnosis-improvement/dxsafety-facilitators-guide.pdf
February 04, 2022 - This reality-based case describes the diagnostic journey of a 49-year-old patient, Joe Kane, with
end … stage renal disease who is receiving weekly hemodialysis. … Add your Overall Ratings into a Summary Score at the end
of the assessment; the range is from 0 to 125 … Summary Score: Add your Overall Rating for each domain into a total score at the end.
-
www.ahrq.gov/sites/default/files/wysiwyg/teamstepps-program/dx-improvement/dxsafety-facilitators-guide.pdf
February 04, 2022 - This reality-based case describes the diagnostic journey of a 49-year-old patient, Joe Kane, with
end … stage renal disease who is receiving weekly hemodialysis. … Add your Overall Ratings into a Summary Score at the end
of the assessment; the range is from 0 to 125 … Summary Score: Add your Overall Rating for each domain into a total score at the end.
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2012.jsp
January 01, 2012 - Standard formulas for a stratified, single–stage cluster sample without replacement should still be used … software packages that perform calculations for numerous statistics arising from the stratified, single–stage … Comorbidity is not present, (1) Comorbidity is present
CM_RENLFAIL
AHRQ comorbidity measure: Renal … More than 50 percent of AHA respondents report statistics for fiscal years, which often end in June or
-
effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
December 01, 2013 - Based on this input, our
overall assessment is that this intervention is in the higher end of the high … Based on this input, our overall assessment is that this
intervention is in the lower end of the high … users of emtricitabine/tenofovir should be
monitored for potential side effects.
48
Decline in renal … Based on this input, our overall assessment is that this intervention is
in the higher end of the high … Based on this input, our overall assessment is that this intervention is in the higher end of the high
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
December 01, 2013 - Based on this input, our
overall assessment is that this intervention is in the higher end of the high … Based on this input, our overall assessment is that this
intervention is in the lower end of the high … users of emtricitabine/tenofovir should be
monitored for potential side effects.
48
Decline in renal … Based on this input, our overall assessment is that this intervention is
in the higher end of the high … Based on this input, our overall assessment is that this intervention is in the higher end of the high
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Xbtq4oDQwVo7KgmSjnnDbz
November 01, 2021 - primary studies informing
the key questions (eMethods in the Supplement) that were pub-
lished from the end … sources (eg, reference
lists, peer reviewers, other SERs)
7796 Citations excluded at title
and abstract stage … Association
between early stage colon neoplasms and
false-negative results from the fecal
immunochemical … Incidental finding of renal masses at
unenhanced CT: prevalence and analysis of features
for guiding
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables1.pdf
August 22, 2011 - Ingredient, Age, Gender, and Race
Note: An asterisk (*) signifies a small cell count (less than 11); ESRD = end … stage renal disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-7-tables.pdf
August 22, 2011 - Ingredient, Age, Gender, and Race
Note: An asterisk (*) signifies a small cell count (less than 11); ESRD = end … stage renal disease.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-7-tables.pdf
August 22, 2011 - Ingredient, Age, Gender, and Race
Note: An asterisk (*) signifies a small cell count (less than 11); ESRD = end … stage renal disease.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-7-tables1.pdf
August 22, 2011 - Ingredient, Age, Gender, and Race
Note: An asterisk (*) signifies a small cell count (less than 11); ESRD = end … stage renal disease.
-
hcup-us.ahrq.gov/db/nation/nis/NISIntroduction2012.pdf
November 01, 2015 - Standard formulas for a stratified, single-stage cluster sample without
replacement should still be … software packages that perform calculations for numerous statistics
arising from the stratified, single-stage … (0) Comorbidity is not present, (1) Comorbidity is present
CM_RENLFAIL AHRQ comorbidity measure: Renal … More than 50 percent of AHA respondents report statistics for fiscal years, which often
end in
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2013.jsp
January 01, 2013 - Standard formulas for a stratified, single–stage cluster sample without replacement should still be used … software packages that perform calculations for numerous statistics arising from the stratified, single–stage … Comorbidity is not present, (1) Comorbidity is present
CM_RENLFAIL
AHRQ comorbidity measure: Renal … More than 50 percent of AHA respondents report statistics for fiscal years, which often end in June or
-
hcup-us.ahrq.gov/reports/methods/2020-04.pdf
January 01, 2020 - The AHRQ QI measures generated for possible inclusion in the NHQDR are described in Table
1 at the end … the AHRQ PQI software, diabetes must be the
principal diagnosis and long-term complications include renal … software, the
following cases are excluded: admissions with a principal diagnosis of
pressure ulcer stage … with the AHRQ PSI
software, the following cases are excluded: obstetric cases; admissions
with acute renal … O43.233 Placenta percreta, third trimester
O43.239 Placenta percreta, unspecified trimester
O72.0 Third-stage
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma_0.xlsx
January 01, 2022 - all six treatment sessions and to attend follow-up visits for at least 12 months (52 weeks) after the end … 11.69), p=NR
TSK: 23.02 (6.26) vs. 25.13 (6.85), p=NR NR NR One serious adverse event occurred at the end … within each treatment arm (yoga=A1 and A2, PT=B1 and B2) did not differ in primary outcomes at the end … Recieved 12 weekly sessions of RFCBT at the end of the study. A vs. … sciatica; ongoing pregnancy; hypertension, cardiovascular disease, diabetes mellitus, liver disease, renal